ALKS vs SNPS · P/E 14, rev $1.56B vs P/E 63, rev $7.05B
Alkermes Plc (ALKS) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the ALKS and SNPS stock pages for the full models.
Not investment advice.